NCT03992508

Brief Summary

To evaluate the role of intermittent pneumatic compression in the treatment of breast cancer-related lymphoedema.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2012

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 17, 2012

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 12, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 20, 2019

Completed
Last Updated

June 20, 2019

Status Verified

June 1, 2019

Enrollment Period

6.2 years

First QC Date

June 12, 2019

Last Update Submit

June 19, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of excess arm volume from baseline

    The volume of every part of the limb was calculated in liter by the truncated cone formula according to circumferential measurements.

    a month

Secondary Outcomes (4)

  • Change of arm pain, heaviness and tightness from baseline

    a month

  • Change of disability from baseline

    a month

  • Change of grip strength from baseline

    a month

  • Change of depression from baseline

    a month

Study Arms (2)

complex decongestive treatment

OTHER

In group 1, the patients were received standard complex decongestive therapy including skin care, manual lymphatic drainage, multi-layer compression bandaging and exercises. During the treatment, written and verbal information was given to the patients about skin care. Manual lymphatic drainage and compressive bandages were applied by a certified physical therapist. The patients received 30-minutes manual lymphatic drainage involving stationary circular, pumping, scooping, and rotary movements. Multi-layer compression bandaging was applied to the affected limb to promote the flow of excess interstitial fluid out of the extremity using a graded pressure for 22-23 hours in a day. The patients strictly followed a lymphoedema exercise program structured with breathing exercise, neck and shoulder range of motion, and stretching exercise to facilitating lymph resorption.

Procedure: complex decongestive therapy

intermittent pneumatic compression

EXPERIMENTAL

In group 2, the patients received experimental intermittent pneumatic compression in addition to the standard complex decongestive therapy. The complex decongestive therapy procedure was the same as above, but additionally, 30 minutes of intermittent pneumatic compression was instituted using a pump (Pulse Press Multi 6 Pro; MJS Healthcare Ltd. UK) operating at 30-40 mmHg of pressure. All groups were given a total of 20 treatment sessions, including daily 5 times a week for 4 weeks.

Device: intermittent pneumatic compressionProcedure: complex decongestive therapy

Interventions

intermittent pneumatic compression
complex decongestive treatmentintermittent pneumatic compression

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • breast cancer-related lymphoedema due to unilateral breast cancer
  • more than 2 cm difference at the circumference measurements or \>10% difference in volume between the two arms
  • completed chemotherapy and radiotherapy

You may not qualify if:

  • bilateral breast cancer
  • primer lymphoedema
  • undergone complex decongestive therapy or other interventions for lymphoedema within 12 months
  • truncal and/or breast oedema
  • continuing chemotherapy and/or radiotherapy
  • active infection
  • current metastases
  • heart failure with arterial and/or venous occlusion
  • elephantiasis
  • impaired cognitive status
  • received physiotherapy within last six months
  • cervical or cranial originated upper extremity problems
  • using any medications that affect the body fluid and electrolyte balance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lymphedema

Interventions

Intermittent Pneumatic Compression Devices

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 12, 2019

First Posted

June 20, 2019

Study Start

August 17, 2012

Primary Completion

October 15, 2018

Study Completion

December 30, 2018

Last Updated

June 20, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share